Evolution of recurrent herpes simplex lesions. An immunohistologic study.
about
Targeted DNA mutagenesis for the cure of chronic viral infectionsUnderstanding natural herpes simplex virus immunity to inform next-generation vaccine designThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureDOCK8 regulates lymphocyte shape integrity for skin antiviral immunityGenital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmissionHerpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.Recent progress in herpes simplex virus immunobiology and vaccine researchExpression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.Homing in on the cellular immune response to HSV-2 in humans.Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanismsReactivation of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodesDeciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa.Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and bloodChronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virusRole of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway.Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.Home sweet home: How do virus specific T cells navigate to the skin?Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursorsPlasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.Chancroid and Haemophilus ducreyi: an update.HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin.Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferonCross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Delayed control of herpes simplex virus infection and impaired CD4(+) T-cell migration to the skin in mouse models of DOCK8 deficiencyImmunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responsesImmunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells.Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in femalesVirus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.The challenge of developing a herpes simplex virus 2 vaccine.The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.
P2860
Q24620150-2A0DE739-FC4B-4182-B55B-73EC3AE272D3Q26741484-8C118AF4-8E09-4B9D-BDD9-413BB5A8C003Q26864344-9D8AA69B-61A8-4111-941F-7D8523400671Q30608340-1CA09ACA-1F5B-4C79-A334-FFD9C3516047Q33336603-37AF0FCD-F602-44C1-B93A-7C2DE04CF80FQ33842412-6E344C6F-7D6B-4161-BE61-C47686FD2B3DQ33850188-40C991CA-BEAD-4D90-89B2-1FB525C79E48Q33893109-19C9226A-04E9-41E5-A289-6CD11A55CB56Q33963713-90D5BA7D-7FD6-49AD-9BA6-BDD93315134CQ34081662-12D0EBFC-C39B-4F6D-A05B-F0AF290151B8Q34081670-75476DB8-5AFA-4B18-B239-EA8A4FDF2024Q34142890-843B8DEA-3245-4BE8-86E7-72AD45121745Q34244404-50DCFED6-877E-4CE9-A473-E133E44015E7Q34279175-80E74CC8-8173-433C-8365-9D8FC39C8C6FQ34386832-6D547292-F44D-4DB1-AAC2-F6E3D1E12C6EQ34389901-726C9973-80DE-43B4-AC1F-79D29550F524Q34407213-26CE996F-6EF2-4032-A4EC-BC74489A78DFQ34459279-43FEEEC0-2770-4731-896D-51E3F06A58F8Q34529794-23F5E362-4016-4E50-9408-33B8C45E3534Q34566092-D69E79BA-AFD4-4E47-BAB9-942893EEFF8CQ34575498-55DC41C7-AE67-4EC9-B1E5-23AC113D894EQ34711496-68490DA0-5FE7-4525-A4A6-B76B3969A045Q34777218-DB2928AE-BE58-4F25-9BB6-5D7A22BC1FD4Q34777412-B2335EF2-0973-409B-8211-6688D776A02AQ35111489-70AB8CEF-B085-4DF9-AD97-6A70E96C944DQ35236237-B7C328B0-9A43-4F9D-9E44-876D1BC96E98Q35535065-0BDA831E-433F-4176-B758-FE02386CEFB7Q35585672-8AF7A57D-316A-4AF6-A130-C0BCBD4A30A0Q35602225-852DEB34-5D2B-4F04-BF45-59F4740423FAQ35634352-064FFD54-8C79-4B71-A1E5-4CDDF44FC682Q35699002-170E308C-BC5E-425B-8D8B-3F2E3F75C7F2Q35832670-62696C21-1AC3-4DEA-9DEE-63F9850FEDF4Q35847995-4A2BEEA6-3F9A-4A56-805C-CE369C8DD76BQ35854117-B5AE28A0-36BD-499D-B768-FF13ACD02F61Q36016560-6F801414-AA74-4322-A8B1-0B167A220BFFQ36173112-82AD4636-0B14-4A14-9800-9F867E55F271Q36267182-69D0CC59-C37C-4723-B547-A86FA870C257Q36633084-03E2BEE4-C6B9-441D-B514-DBA202A2FFF7Q36671106-39628843-BE55-4BE7-821B-C36AA82B65F1Q36765590-1AF36D2C-C26F-4AB9-8CDC-5A73109F5A20
P2860
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@ast
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@en
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@nl
type
label
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@ast
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@en
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@nl
prefLabel
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@ast
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@en
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@nl
P2093
P2860
P356
P1476
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
@en
P2093
A C Miller
A L Cunningham
R R Turner
T C Merigan
P2860
P304
P356
10.1172/JCI111678
P407
P577
1985-01-01T00:00:00Z